Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus

L. D. Lilien, G. Srinivasan, T. F. Yeh, R. S. Pildes

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

Original languageEnglish
Pages (from-to)73-77
Number of pages5
JournalPediatric Pharmacology
Volume5
Issue number1
Publication statusPublished - Jan 1 1985
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus'. Together they form a unique fingerprint.

  • Cite this